|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Propylene glycol dinitrate | CAS 6423-43-4 | ||
| CH3CNO2OHCHNO2OH | RTECS TY6300000 | ||
|
Synonyms & Trade Names PGDN; Propylene glycol-1,2-dinitrate; 1,2-Propylene glycol dinitrate |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.05 ppm (0.3 mg/m3) [skin] | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 6.79 mg/m3 | ||
|
Physical Description Colorless liquid with a disagreeable odor. [Note: A solid below 18°F.] |
|||
|
MW: 166.1 |
BP: ? |
FRZ: 18°F |
Sol: 0.1% |
|
VP(72°F): 0.07 mmHg |
IP: ? |
|
Sp.Gr(77°F): 1.23 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Liquid | |||
|
Incompatibilities & Reactivities Ammonia compounds, amines, oxidizers, reducing agents, combustible materials [Note: Similar to Ethylene glycol dinitrate in explosion potential.] |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes; conjunctivitis; methemoglobinemia; headache, impaired balance, visual disturbance; in animals: liver, kidney damage | |
|
Target Organs
Eyes, central nervous system, blood, liver, kidneys |
|
| See also: INTRODUCTION |